Psoriatic Disease Management Suboptimal
At Maui Derm Hawaii, held January 22-26, 2024, Linda Stein-Gold, MD, presented as part of “Challenging Cases in Psoriasis.”
Read MoreJan 23, 2024
At Maui Derm Hawaii, held January 22-26, 2024, Linda Stein-Gold, MD, presented as part of “Challenging Cases in Psoriasis.”
Read MoreJan 22, 2024
Social determinants of health influenced the achievement of textbook oncological outcomes and overall survival in non-small cell lung cancer.
Read MoreJan 22, 2024
Lymphovascular invasion is an independent predictor for shorter recurrence-free survival for patients with stage I NSCLC.
Read MoreJan 21, 2024
Investigators concluded that pre-surgery nutrition support may cut hospital stays for patients...
Read MoreJan 20, 2024
Researchers concluded that vedolizumab (vedo) gut-specific targeting spared passive immunity in...
Read MoreJan 19, 2024
The following is a summary of “Exploring the Relationship Between Patient Symptoms and Provider...
Read MoreJan 18, 2024
The following is a summary of “Continuous Monitoring of CRP, IL-6, and Calprotectin in...
Read MoreJan 15, 2024
At the 2024 Winter Clinical Derm Conference, April W. Armstrong, MD, MPH, presented as part of the session “Clinical and Therapeutic Pearls in Psoriasis.”
Read MoreJan 15, 2024
At the 2024 Winter Clinical Derm Conference, April Armstrong, MD, MPH, and Joseph F. Merola, MD, MMSc, presented “Debate: IL-17 vs IL-23 Blockers for Psoriasis.”
Read MoreJan 15, 2024
At the 2024 Winter Clinical Dermatology Conference, held January 12-17, 2024 in Honolulu, Mark Lebwohl, MD, presented the session “Late Breakers in Psoriasis.”
Read MoreJan 8, 2024
Patients reporting increased fatigue have a higher hazard of death compared with those who did not after adjusting for covariates.
Read MoreDec 22, 2023
Treatment that includes acalabrutinib can improve progression-free survival in treatment-naïve patients with chronic lymphocytic leukemia.
Read MoreDec 22, 2023
Dr. Reckamp co-authored a paper that addresses the need for cautious progression from phase 1 to phase 3 trials for advanced NSCLC, summarized here.
Read MoreDec 18, 2023
A sandwich treatment model that includes acalabrutinib and rituximab in combination with R-DHAOx chemotherapy shows encouraging results in phase 2 trial.
Read MoreDec 18, 2023
Patients with rare inherited retinal diseases often must undertake a diagnostic odyssey before receiving a correct diagnosis.
Read MoreDec 14, 2023
Do you remember the MS research presented at AAN? Test your knowledge now and see how you rank!
Read MoreDec 14, 2023
Do you remember the psoriasis research presented at Fall Clinical Dermatology Conference 2023? Test your knowledge now!
Read MoreDec 11, 2023
In age-related macular degeneration, depression can directly impact patient care through loss to follow-up, cancellations, and lack of treatment adherence.
Read MoreDec 9, 2023
At 2023 NACLC, Heather Law, MA, presented a recap of “Associations of HRQOL with daily functioning/communication with care teams in patients with ALK+ NSCLC.”
Read MoreDec 6, 2023
Decision support tools help patients with MS more effectively engage with their providers and adhere to their treatment.
Read More